Cancer Center Support Grant (CCSG) Programs

Medicine & Life Sciences

1. Neoplasms 100%
2. Prostatic Neoplasms 52%
3. Breast Neoplasms 39%
4. Radiotherapy 38%
5. Survival 36%
6. Glioblastoma 35%
7. Glioma 34%
8. Therapeutics 33%
9. Palliative Care 30%
10. Genes 28%
11. Brain 28%
12. Radiation 27%
13. Cancer Survivors 26%
14. Neoplasm Metastasis 24%
15. Quality of Life 24%
16. Pancreatic Neoplasms 24%
17. Catenins 23%
18. Drug Therapy 23%
19. Rheumatoid Arthritis 23%
20. Hepatocellular Carcinoma 22%
21. Confidence Intervals 21%
22. Magnetic Resonance Imaging 19%
23. Pain 18%
24. Liver 17%
25. Odds Ratio 17%
26. Arachidonate 15-Lipoxygenase 16%
27. Systematic Reviews 15%
28. Growth 15%
29. Fatigue 15%
30. Randomized Controlled Trials 15%
31. Lipoxygenase 14%
32. Decision Support Techniques 14%
33. Exercise 14%
34. Carcinogenesis 14%
35. Recurrence 13%
36. Proteins 13%
37. delta catenin 13%
38. White Matter 13%
39. Population 13%
40. Breast 13%
41. Health 12%
42. Phenotype 12%
43. Early Detection of Cancer 12%
44. Prostate 12%
45. Mutation 12%
46. Adenocarcinoma 12%
47. Stem Cells 12%
48. Androgens 12%
49. Melanoma 12%
50. Colorectal Neoplasms 12%
51. Neuroimaging 12%
52. Brain Neoplasms 11%
53. Methylation 11%
54. Prostatectomy 11%
55. Cost-Benefit Analysis 11%
56. Costs and Cost Analysis 11%
57. Gene Expression 11%
58. Depression 11%
59. Hispanic Americans 11%
60. Chromatin 11%
61. Integrins 10%
62. Brachytherapy 10%
63. DNA 10%
64. Tomography 10%
65. Physicians 10%
66. Clinical Trials 10%
67. Apoptosis 10%
68. Rheumatology 10%
69. Child 9%
70. Symptom Assessment 9%
71. Ovarian Neoplasms 9%
72. Transcription Factors 9%
73. Cadherins 9%
74. Knee Osteoarthritis 9%
75. Biomarkers 9%
76. Survivors 9%
77. Datasets 9%
78. Guidelines 9%
79. Mortality 8%
80. Cohort Studies 8%
81. Radiation Oncology 8%
82. Decision Making 8%
83. Cell Line 8%
84. Gray Matter 8%
85. Lung Neoplasms 8%
86. Diffusion Tensor Imaging 8%
87. Magnetic Resonance Spectroscopy 8%
88. oleandrin 8%
89. Renal Cell Carcinoma 8%
90. Education 8%
91. Communication 8%
92. Neuroblastoma 8%
93. Carcinoma 7%
94. Smoking 7%
95. Referral and Consultation 7%
96. Genome 7%
97. Drosophila 7%
98. Osteoarthritis 7%
99. Case-Control Studies 7%
100. Extremities 7%